Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.86
+0.20 (3.53%)
At close: Jul 2, 2026, 4:00 PM EDT
5.98
+0.12 (2.04%)
After-hours: Jul 2, 2026, 6:29 PM EDT
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $137.46 million as of July 2, 2026. Its market cap has increased by 54.49% in one year.
Market Cap
137.46M
Enterprise Value
86.73M
1-Year Change
54.49%
Ranking
Category
Stock Price
$5.86
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $137.46M, an increase of 1,061.24%. That is a compound annual growth rate of 101.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 137.46M | 13.26% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 151.36M |
| Molecular Partners AG | 148.48M |
| Agenus | 145.33M |
| Spruce Biosciences | 144.52M |
| Aldeyra Therapeutics | 136.93M |
| YD Bio | 133.61M |
| Polaryx Therapeutics | 133.03M |
| Genelux | 132.78M |